Arrowhead's Plozasiran Reduces Triglyceride Rich Lipoproteins in Patients with Mixed Hyperlipidemia

Press/Media

Period	3 Jun 2024

Media coverage

Title	Arrowhead's Plozasiran Reduces Triglyceride Rich Lipoproteins in Patients with Mixed Hyperlipidemia
Media name/outlet	AZO Life Sciences
Country/Territory	United Kingdom
Date	3/06/24
URL	ct.moreover.com/?a=53964842653&p=1gw&v=1&x=hWoXvjKZLkRzzv6EqgWSvw
Persons	Robert Sidney Rosenson